MSR29 Application of Bayesian Multi-Parameter Evidence Synthesis to Achieve Clinical Plausibility of Lifetime Survival Extrapolations in First-Line Advanced Non-Small Cell Lung Cancer (aNSCLC)
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1565
https://www.valueinhealthjournal.com/article/S1098-3015(23)01665-0/fulltext
Title :
MSR29 Application of Bayesian Multi-Parameter Evidence Synthesis to Achieve Clinical Plausibility of Lifetime Survival Extrapolations in First-Line Advanced Non-Small Cell Lung Cancer (aNSCLC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01665-0&doi=10.1016/j.jval.2023.03.1565
First page :
Section Title :
Open access? :
No
Section Order :
10956